Sanofi is returning to the takeover trail. Photograph: AFP

French drugmaker Sanofi went public with a $9.3 billion (€8.2bn) offer to buy Medivation on Thursday, setting up what could be a lengthy takeover figh(...)

Declan Connolly with his wife Charlotte, who is believed to be the only person in Ireland suffering from Degos disease. Photograph: James Flynn/APX

A Mullingar man has appealed to the Government to fund an experimental treatment for his wife with one of the world’s most expensive drugs in order to(...)

Report suggested a campaign be launched by the HSE to promote greater use of generic drugs. Photograph: Getty Images

Pharmacists should be offered financial incentives to supply certain generic drugs as part of a drive to reduce drugs costs in Ireland, an Oireachtas (...)

US Democratic presidential candidate Hillary Clinton: her tweet sent the Nasdaq biotech index down by almost 5 per cent in early New York trading. Photograph: Yuri Gripas/Reuters

Hillary Clinton, Democratic frontrunner in the US presidential race, knocked $15 billion (€13.5 billion) from the value of US biotech stocks on Monday(...)

Photograph: Stephen Kelly/PA Wire.

The Health Service Executive considered suing a US pharmaceutical firm accused of charging an “astronomical” price for a life-saving drug, internal do(...)

Julie O’Neill at the site in College Park, Blanchardstown. When it is completed, Alexion will have invested €508 million in the State. Photograph: Dara Mac Dónaill/The Irish Times

It’s been a long day already, but, with a quick sip of a soft drink, Julie O’Neill gets stuck in. Earlier in the day, O’Neill had announced a €450 mil(...)

Julie O’Neill of Alexion Pharmaceuticals: “I don’t think we are at a stage in the economic recovery where businesses in any sense can afford to give those level of pay cuts [back].” Photograph: The Irish Times

Ireland’s economy is not yet sufficiently recovered to consider reversing cuts in pay imposed during the years of austerity, according to a former pre(...)

Alexion, which makes Soliris, one of the world’s most expensive drugs, is to invest a further € 450 million to extend its Dublin facility over the next four years.

Biopharma group Alexion has announced plans for a major expansion of its Irish business.Alexion, which is still building the first page of its planne(...)

The maker of one of the world’s most expensive medicines, whose price has been described by the HSE as “exorbitant” and “astronomical”, have refused t(...)

The Health Service Executive (HSE) has decided to make a life-saving Soliris drug available to Irish patients despite criticising its “exorbitant” and ‘astronomical’ cost.

A life-saving drug which costs about €430,000 per patient annually is to be made available in Ireland, even though the Health Service Executive (HSE) (...)